Biganib (Brigatinib) 90mg/180mg | Generic ALK Inhibitor Bangladesh | GLT

REQUEST A QUOTE

Tap "Request a Quote" to open WhatsApp — the product details are already filled in. Just add your quantity and destination country.

  • We reply within 24 hours with pricing, availability & COA
  • Serves individuals and institutions worldwide

Prefer email? [email protected] · +86 15234153837

Share
Product description

Generic Information: Biganib (Bangladesh)

Biganib is a Bangladeshi generic of brigatinib, manufactured by Drug International Limited (DIL). It is supplied in 90 mg and 180 mg tablets, available in several pack sizes including 90 mg in 10-, 30-, and 60-tablet packs and 180 mg in 7- and 30-tablet packs. As a generic second-generation ALK inhibitor, Biganib delivers the same active ingredient as the originator at a much lower, out-of-pocket-friendly price for ALK-positive lung cancer therapy.

What Is Biganib Used For?

Biganib is used to treat anaplastic lymphoma kinase-positive (ALK+) non-small cell lung cancer, including in patients who have progressed on or cannot tolerate crizotinib. The wide range of pack sizes makes it convenient for both the 90 mg lead-in phase and the 180 mg maintenance phase of the standard brigatinib regimen.

How Does Biganib (Brigatinib) Work?

The brigatinib in Biganib is a next-generation ALK tyrosine kinase inhibitor that also targets ROS1, IGF-1R, and FLT-3. By blocking ALK-driven signaling, it slows tumor growth and, because it crosses the blood-brain barrier, it is particularly valuable against brain metastases. The generic delivers the same pharmacology as the originator, which is why it can be used as a cost-saving substitute.

Indications

Biganib is indicated for adults with ALK-positive, locally advanced or metastatic NSCLC. Treatment should only begin after an ALK rearrangement is confirmed by genetic testing. It is not suitable for ALK-negative disease and is not indicated for small-cell lung cancer.

Dosage

The standard regimen begins with 90 mg once daily for 7 days, followed by 180 mg once daily if tolerated. Tablets are taken with or without food and swallowed whole. If a dose is missed or vomited, do not take an extra tablet — continue with the next scheduled dose. Any gap of 14 days or longer requires a fresh 7-day 90 mg lead-in.

Side Effects

Common side effects include diarrhea, rash, cough, high blood pressure, fatigue, nausea, muscle pain, and headache. Blood pressure should be checked regularly, and diarrhea is usually manageable with supportive care and hydration. Interstitial lung disease is uncommon but serious and requires stopping the medicine permanently if it is confirmed.

Storage

Store Biganib below 30°C in a dry place, in its original packaging, and away from children. No refrigeration is required.

Why Choose the GLT?

For patients paying out of pocket, a generic such as Biganib from Bangladesh offers a major price advantage over the originator brand. The originator's Western list price is very high, while Bangladeshi generic brigatinib is priced far more affordably, which can make years of daily therapy financially sustainable. GLT sources from established manufacturers and helps buyers obtain the documentation needed for safe import.

How to Order

To order Biganib through GLT, contact us on WhatsApp at +86 15234153837 or email [email protected]. Let us know the strength and pack size you need and your destination, and we will confirm availability, sourcing origin, and delivery terms for your region.

FAQ

Is Biganib a generic of Alunbrig? Yes. Biganib is a Bangladeshi generic of brigatinib, the same active ingredient as Alunbrig, produced by Drug International Limited.

What pack sizes does Biganib come in? Biganib is available in 90 mg (10, 30, and 60 tablets) and 180 mg (7 and 30 tablets), covering both the lead-in and maintenance phases of the dosing schedule.

Can I buy generic brigatinib online? Many patients source generic brigatinib through international suppliers such as GLT. Always confirm the supplier is legitimate and provides proper documentation before ordering.

Related Oncology Products

Barinib (Baricitinib) 2mg | Generic JAK1/JAK2 Inhibitor | Drug International Limited | GLT

Generic baricitinib (JAK1/JAK2 inhibitor) by Drug International Limited (Bangladesh) — an affordable alternative to Olumiant...

Tixepa (Tirzepatide) 20mg/2mL & 30mg/2mL Multi-Dose Pen | Drug International | GLT

Tixepa — Drug International Limited (DIL) tirzepatide multi-dose pen, two official strengths (Tixepa-5 = 20mg/2mL,...

AVATODX (Avatrombopag) 20mg*30 Tablets | Bigbear Pharmaceutical Laos | GLT

AVATODX — avatrombopag 20mg by Bigbear Pharmaceutical (Lao) Co., Ltd., Lao Reg. 06L0985/23, 30-tablet bottle

XinKePing 欣可平 (Avatrombopag) 20mg*10 Tablets | Nanjing Hencer China | GLT

XinKePing — API-plus-tablet integrated avatrombopag from Nanjing Hencer Pharmaceutical (Jemcare group), China Mainland

Zepbound (Tirzepatide) 2.5–15mg/0.5mL Single-Dose Pen | Eli Lilly USA | GLT

Zepbound — Eli Lilly tirzepatide single-dose pen, six US strengths (2.5–15mg/0.5mL) for chronic weight management...

Baricent (Baricitinib) 2mg | Generic JAK1/JAK2 Inhibitor | Incepta Pharmaceuticals Ltd. | GLT

Generic baricitinib (JAK1/JAK2 inhibitor) by Incepta Pharmaceuticals Ltd. (Bangladesh) — an affordable alternative to Olumiant...

Orforglipron (LuciOrfor) 0.8–17.2mg Tablets | Laos Generic Oral GLP-1 | GLT

Lucius Pharmaceuticals (Laos) generic orforglipron, 6-dose titration for weight management

Olumiant (Baricitinib) 2mg/4mg Tablets | JAK1/JAK2 Inhibitor | Eli Lilly USA | GLT

Eli Lilly's selective JAK1/JAK2 inhibitor for rheumatoid arthritis, atopic dermatitis and severe alopecia areata.